title: Expression and function of the calcium-sensing receptor in juxtaglomerular cells.
abstract: Calcium-sensing receptors sense and translate micromolar changes of extracellular calcium into changes in intracellular calcium. Renin, a component of the renin-angiotensin system, is synthesized by, stored in, and released from the juxtaglomerular cells through a cAMP-dependent pathway. Increased intracellular calcium inhibits the adenylyl cyclase isoform type V, cAMP formation, and renin release from juxtaglomerular cells. We hypothesized that calcium-sensing receptors are expressed in juxtaglomerular cells and mediate changes in intracellular calcium and renin release. To test this we used primary cultures of isolated mouse juxtaglomerular cells in which we ran RT-PCR, Western blots, and immunofluorescence. RT-PCR showed a positive band at the expected 151 bp consistent with calcium-sensing receptor. Western blots showed a 130- to 150-kDa band confirming the calcium-sensing receptor in juxtaglomerular cells. Immunofluorescence and confocal microscopy using 2 different antibodies against the calcium-sensing receptor in juxtaglomerular cells showed positive fluorescence in the juxtaglomerular cells, which also had positive labeling for renin. To test whether calcium-sensing receptors regulate renin release, juxtaglomerular cells were incubated with a calcium-sensing receptor agonist, the calcimimetic cinacalcet-HCl, at concentrations of 50 and 1000 nmol/L in 0.25 mmol/L of calcium medium. Cinacalcet-HCl decreased juxtaglomerular cell cAMP formation to 47.3+/-6.8% and 44.2+/-9.7% of basal, respectively (P<0.001), and decreased renin release from 541.9+/-86.2 to 364.6+/-64.1 (P<0.05) and 279.6+/-56.9 (P<0.005) ng of angiotensin I per milliliter per hour per milligram of protein, respectively. We conclude that juxtaglomerular cells express the calcium-sensing receptor and that their activation leads to inhibition of adenylyl cyclase-V activity, decreasing cAMP formation and suppressing renin release.
authors.affiliation: Department of Medicine, Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, MI 48202, USA.
authors.forename: M Cecilia
authors.initials: MC
authors.lastname: Ortiz-Capisano
authors.forename: Pablo A
authors.initials: PA
authors.lastname: Ortiz
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Garvin
authors.forename: Pamela
authors.initials: P
authors.lastname: Harding
authors.forename: William H
authors.initials: WH
authors.lastname: Beierwaltes
mesh_terms: D000818:Animals; D002118:Calcium / Q000502:physiology; D020013:Calcium Signaling / Q000502:physiology; D002478:Cells, Cultured; D000069449:Cinacalcet; D000242:Cyclic AMP / Q000378:metabolism; D005786:Gene Expression Regulation; D007606:Juxtaglomerular Apparatus / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D009281:Naphthalenes / Q000494:pharmacology; D044169:Receptors, Calcium-Sensing / Q000378:metabolism*; D012083:Renin / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology